And the answers are no, no, and no, said Alice Yuk-Yan Cheng, MD, an associate professor of medicine at University of Toronto, during a presentation on the retatrutide trial results at an American Diabetes Association meeting on June 6
Prescriptions for GLP-1s have more than quadrupled since 2020, A 2024 KFF Health Poll survey found that as many as one in eight (12%) adults have taken a GLP-1 drug, with as many as 6% are currently using GLP-1 drugs
However, patients with active eating disorders require careful clinical oversight before starting GLP-1 therapy, and the decision to add semaglutide in the context of bulimia treatment should involve the treating mental health provider, not just a prescribing physician
For detailed information on compounded formulation shelf life, see our guide on compounded tirzepatide expiration dates
Lilys SURMOUNT-OSA trial will begin in March 2024 to evaluate the effect of Mounjaro on sleep apnea
These pharmacokinetic limitations explain why the most successful applications have been topical (where the peptide is applied directly to the target tissue) rather than systemic